Skip to main content
Download PDF

Dysregulation of BDNF/TrkB signaling mediated by NMDAR/Ca2+/calpain might contribute to postoperative cognitive dysfunction in aging mice

Journal of Neuroinflammation volume 17, Article number: 23 (2020) Cite this article

Abstract

Background

Postoperative cognitive decline (POCD) is a recognized clinical phenomenon characterized by cognitive impairments in patients following anesthesia and surgery, yet its underlying mechanism remains unclear. Brain-derived neurotrophic factor (BDNF) plays an important role in neuronal plasticity, learning, and memory via activation of TrkB-full length (TrkB-FL) receptors. It has been reported that an abnormal truncation of TrkB mediated by calpain results in dysregulation of BDNF/TrkB signaling and is associated with cognitive impairments in several neurodegenerative disorders. Calpains are Ca2+-dependent proteases, and overactivation of calpain is linked to neuronal death. Since one source of intracellular Ca2+ is N-methyl-d-aspartate receptors (NMDARs) related and the function of NMDARs can be regulated by neuroinflammation, we therefore hypothesized that dysregulation of BDNF/TrkB signaling mediated by NMDAR/Ca2+/calpain might be involved in the pathogenesis of POCD.

Methods

In the present study, 16-month-old C57BL/6 mice were subjected to exploratory laparotomy with isoflurane anesthesia to establish the POCD animal model. For the interventional study, mice were treated with either NMDAR antagonist memantine or calpain inhibitor MDL-28170. Behavioral tests were performed by open field, Y maze, and fear conditioning tests from 5 to 8 days post-surgery. The levels of Iba-1, GFAP, interleukin-1β (IL-1β), IL-6, tumor necrosis factor-α (TNF-α), NMDARs, calpain, BDNF, TrkB, bax, bcl-2, caspase-3, and dendritic spine density were determined in the hippocampus.

Results

Anesthesia and surgery-induced neuroinflammation overactivated NMDARs and then triggered overactivation of calpain, which subsequently led to the truncation of TrkB-FL, BDNF/TrkB signaling dysregulation, dendritic spine loss, and cell apoptosis, contributing to cognitive impairments in aging mice. These abnormities were prevented by memantine or MDL-28170 treatment.

Conclusion

Collectively, our study supports the notion that NMDAR/Ca2+/calpain is mechanistically involved in anesthesia and surgery-induced BDNF/TrkB signaling disruption and cognitive impairments in aging mice, which provides one possible therapeutic target for POCD.

Background

Postoperative cognitive decline (POCD) is a recognized clinical phenomenon characterized by cognitive impairments in patients after anesthesia and surgery, especially in the elderly [1]. POCD receives increasing attention because it negatively affects cognitive domains such as memory, attention, and concentration, which are associated with a prolonged hospitalization, a reduced quality of life, and an increased morbidity and mortality [2, 3]. However, its pathophysiology remains unknown.

Brain-derived neurotrophic factor (BDNF) is a neurotrophin widely expressed in the central nervous system, which plays a critical role in neuronal survival and differentiation, and synaptic plasticity through activation of its full-length receptor (TrkB-FL) [4, 5]. Dysregulation of BDNF/TrkB signaling contributes to many pathological processes, including traumatic brain injury [6, 7], brain ischemia [8, 9], and neurodegenerative diseases [10, 11]. However, truncated isoforms of TrkB receptors (TrkB-TC) act as negative modulators of TrkB-FL receptors [12, 13], and alterations in TrkB-TC:TrkB-FL ratio are thought to cause and/or reflect dysregulation of BDNF/TrkB signaling [8, 14]. In an in vitro study, excitotoxic stimulation of cultured rat hippocampal neurons with glutamate downregulated TrkB-FL while upregulated TrkB-TC receptors, which results in dysregulation of BDNF/TrkB signaling [14]. In our previous study, we have showed that decreased expression of BDNF is involved in the pathogenesis of POCD [15]. However, whether TrkB-TC also plays a mechanistic role in POCD remains unclear.

Calpains are intracellular Ca2+-dependent cysteine proteases that play a physiologic role by the cleavage of several substrates, including the neurotrophin receptor TrkB [11], cytoskeletal proteins, and membrane receptors [16]. A calpain-dependent truncated form of TrkB-FL has been reported to participate in neurodegenerative diseases, such as AD [11] and epilepsy [17]. The overactivation of calpain could lead to changes in hippocampal structure and function [18] and also be linked to neuronal death [19]. Calpain is overactivated by increased Ca2+ concentrations and one source of intracellular Ca2+ is NMDARs related. Importantly, one recent study showed that amyloid-β peptide (Aβ) induced the overactivation of NMDARs and calpain, and then triggered the formation of a truncated isoform (TrkB-T′) and an intracellular domain (ICD) fragment, and ultimately disrupted BDNF/TrkB signaling, which can be prevented by a NMDAR antagonist memantine [20]. However, it remains unclear whether the overactivation of NMDARs and a calpain-dependent truncated form of TrkB-FL is involved in the development of POCD.

Inflammation has been proved to be a potential source of reactive oxygen species for inducing NMDARs hypofunction and nonsteroidal anti-inflammatory drugs (NSAIDs) can improve impaired NMDAR-dependent synaptic plasticity and age-related cognitive dysfunction [21]. In addition, accumulating evidence suggests that neuroinflammation plays an initial and central role in anesthesia and surgery-induced cognitive impairments [15, 22, 23]. Upon all these points, we hypothesized that anesthesia and surgery-induced neuroinflammation overactivated NMDARs, and the abnormal activation of NMDARs triggered the overactivation of calpain, which subsequently led to the truncation of TrkB-FL, BDNF/TrkB signaling dysregulation, dendritic spine loss, and cell apoptosis, contributing to cognitive impairments in aging mice.

Materials and methods

Animals

One hundred and forty-four 16-month-old male C57BL/6 mice (26–36 g) were obtained from the Animal Center of Southeast University, Nanjing, China. Animals were housed in groups of 3–5 individuals per cage in a standard condition with access to food and water ad libitum in a colony room kept at 19–22 °C and 40–60% humidity, under a 12-h light/dark cycle (light from 07:00 to 19:00). The experiments began after all the animals acclimated to the environment for 2 weeks. The study protocol was approved by the Ethics Committee of Zhongda Hospital, Medical School, Southeast University, and all procedures were performed in accordance with the approved guidelines. The schematic timeline of the experimental procedure is summarized in Fig. 1.

Fig. 1
figure 1

Schematic timeline of the experimental procedure. The mice were treated with MEM (a NMDAR antagonist, 20 mg/kg) or MDL-28170 (a calpain inhibitor, 20 mg/kg) intraperitoneally (i.p.) before anesthesia, and the surgery was performed immediately after 30 min exposure to isoflurane. Twenty-four hours later, the mice were sacrificed for Western blot and immunofluorescence detection. For the behavioral study, mice underwent anesthesia and surgery on day 0. The mice were treated with MEM (20 mg/kg) or MDL-28170 (20 mg/kg) i.p. before anesthesia, and once daily for the subsequent 5 consecutive days. Behavioral tests were performed from 5 to 8 days post-surgery with open field, Y maze, and fear conditioning tests, respectively. Three hours after behavioral tests at 8 days post-surgery, the brains of mice were collected for Western blot and Golgi-Cox staining

Full size image

Animal model

Exploratory laparotomy was performed under isoflurane anesthesia described as our previous studies [15, 23]. Mice were anesthetized in an anesthesia chamber prefilled with 1.5% isoflurane in oxygen. The surgery was performed immediately after 30 min exposure to isoflurane. An abdominal median incision approximately 1 cm was made to allow penetrating the peritoneal cavity. Then the viscera, intestine, and musculature were explored by the operator. Sterile 4-0 chromic gut sutures were used to suture the peritoneal lining and skin. In order to prevent infection, the wound was dressed with polysporin (Pfizer, USA). The surgical procedure was also under isoflurane anesthesia and lasted for 10 min. For the mice that served as controls, neither anesthesia nor surgery was performed.

Drugs

The NMDAR antagonist memantine (MEM, 20 mg/kg, Sigma, St Louise, MO, USA) [24] was intraperitoneally (i.p.) administered to the mice before anesthesia and then once daily for subsequent 5 consecutive days. The calpain inhibitor, MDL-28170 (20 mg/kg, Sigma, St Louise, MO, USA) [25], was administered to the mice by i.p. before anesthesia and then once daily for the subsequent 5 consecutive days. The selected doses are based on previous studies demonstrating memantine and MDL-28170 confers neuroprotective effects [24, 25].

Open field

A white opaque plastic chamber (40 cm × 40 cm × 40 cm, XR-XZ301, Shanghai Softmaze Information Technology Co., Ltd., Shanghai, China) was used as the open-field arena. The open-field test was performed at 5 days post-surgery to assess the exploratory locomotor activity. Each mouse was placed in the center of the arena and left to explore it for 5 min while activity was automatically recorded by a video tracking system.

Y maze

The Y maze is a symmetrical three-arm maze (XR-XY1032; Shanghai Softmaze Information Technology Co., Ltd., Shanghai, China) and is used to evaluate the spontaneous alternation performance at 6 days post-surgery. Each mouse was placed in the center of the Y maze and could explore freely throughout the three different arms of the maze during an 8-min session. The sequence and total number of arms entered were recorded. Arm entry was complete when the hind paws of the mouse had been completely placed in the arm. The alteration was determined from successive consecutive entries to the three different arms on overlapping triads in which all arms were represented. For example, a sequence of entries to the three arms ABC, ACBABACABA, would generate four “successful” alternations, ACB, CBA, BAC, and CAB. Percentage alternation is the number of triads containing entries into all three arms divided by the maximum possible alternations (the total number of arms entered minus 2) × 100. The re-entry into the same arm was not counted for analysis [26].

Fear conditioning

Mice were trained for fear conditioning at 7 days post-surgery. Each mouse was placed into a conditioning chamber (XR-XC404; Shanghai Softmaze Information Technology Co., Ltd., Shanghai, China) and allowed to explore freely for 3 min. Then a 30-s tone (70 db, 3 kHz) was delivered followed by a 2-s foot shock (0.7 mA). After that, the mouse stayed in the chamber for another 30 s and then returned to the home cage. Contextual fear conditioning (a hippocampus-dependent task) was assessed 24 h after training. For the contextual fear conditioning, each mouse was placed back into the same chamber in which they were explored for 5 min without tone or foot shock and scored for the freezing behavior. Freezing behavior was defined as the absence of all visible movement except for respiration. Given that no difference was observed in the auditory-cued fear test (a hippocampus-independent task) between control and surgery group in our previous studies [15, 23], the test was not performed in the present study.

Western blot

The entire dissected hippocampus was harvested and subjected to Western blot analysis. The samples were lysed as described previously [15, 23]. Protein concentration was determined by BCA protein assay kit (Beyotime, China). Equivalent amounts of proteins per lane were separated on SDS-PAGE gels and then transferred to polyvinylidinene fluoride (PVDF) membranes. Membranes were blocked with 5% skimmed milk in Tris-buffered saline with Tween (TBST) for 1 h at room temperature. And then the membranes were incubated at 4 °C overnight with primary antibodies including rabbit anti-IL-1β (1:500; Abcam, Cambridge, UK), rabbit anti-IL-6 (1:1000; Affinity, Cincinnati, USA), rabbit anti-TNF-α (1:500, Cell Signaling Technology, Danvers, MA, USA), rabbit anti-GluN2A (1:1000; Abcam, Cambridge, UK), rabbit anti-GluN2B (1:1000; Abcam, Cambridge, UK), mouse anti-αIIspectrin (1:200; Santa Cruz Biotechnology, Dallas, TX, USA), mouse anti-BDNF (1:500; Abcam, Cambridge, UK), mouse anti-TrkB (1:300; Santa Cruz Biotechnology, Dallas, TX, USA), rabbit anti-bax (1:200; Santa Cruz Biotechnology, Dallas, TX, USA), mouse anti-bcl-2 (1:300; Santa Cruz Biotechnology, Dallas, TX, USA), rabbit anti-caspase3 (1:1000; Cell Signaling Technology, Danvers, MA, USA), mouse anti-GAPDH (1:5000; ProteinTech group, Chicago, USA), and rabbit anti-β-tubulin (1:3000; ProteinTech group, Chicago, USA). After washing in TBST three times, the membranes were incubated for 1 h at room temperature with goat anti-rabbit and goat anti-mouse IgG-horseradish peroxidase-conjugated secondary antibodies (1:7000, Bioworld Technology, St. Louis Park, MN, USA). The protein bands were detected by enhanced chemiluminescence, exposed onto X-ray film, and quantitated with Image J software (National Institutes of Health, Bethesda, MD, USA).

Immunofluorescence

Mice were deeply anesthetized with 2% sodium pentobarbital in saline (60 mg/kg, i.p.; Sigma, St Louise, MO, USA) and transcardially perfused with saline, followed by 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS; pH 7.4). Brains were removed and postfixed in 4% PFA for 2 h and dehydrated in 30% sucrose at 4 °C overnight and then embedded in O.C.T. compound. The brains were cut coronally into 10-μm-thick sections from bregma − 1.70 to − 2.30 by a freezing microtome and mounted on glass slides. The sections were blocked with 1% bovine serum albumin (BSA) for 1 h at room temperature. And then the sections were incubated with primary antibodies: rabbit anti-Iba1 (1:500, Wako Pure Chemical Industries, Osaka, Japan) and rabbit anti-GFAP (1:1000, Sigma, St Louise, MO, USA) in 1% BSA at 4 °C overnight. Sections were washed with PBS three times and incubated with goat anti-rabbit IgG-FITC (1:600; Bioworld Technology, St. Louis Park, MN, USA) and goat anti-rabbit IgG-Cy3 (1:600; Bioworld Technology, St. Louis Park, MN, USA) for 1 h at room temperature. After washing out the secondary antibodies, sections were incubated with 4′,6-diamidino-2-pheny-lindole (DAPI) for nuclear staining. Fluorescent images were captured by a confocal microscope (Olympus, FV1000, Japan). Six sections of the hippocampus per mouse were analyzed by ImageJ (National Institutes of Health, Bethesda, MD, USA) for immunofluorescence analysis. Three non-overlapping fields of each section in the hippocampal Cornu Ammonis 1 (CA1) area was randomly acquired by a counting frame size of 0.4 mm2. Positively stained areas were defined that the number of pixels per image with intensity in which was above a predetermined threshold level. The immunoreactivity of a protein was quantified by percentage area with positive staining to the total area of the imaged field. All quantitative analyses were performed by an experimenter blinded to the group of each sample.

Golgi-Cox staining

The brains of mice were processed at 8 days post-surgery for Golgi-Cox staining [27] using a Golgi Stain Kit (#PK401, FD NeuroTechnologies, Columbia, MD, USA). Briefly, mice were deeply anesthetized by sodium pentobarbital in saline (60 mg/kg, i.p.; Sigma, St Louise, MO, USA) and rapidly sacrificed. The brains were removed as quickly as possible; rinsed in double-distilled water; immersed in impregnation solution, which was a mixture of solutions A and B; and stored in the dark at room temperature (22–25 °C) for 3 weeks. Next, the brains were transferred into solution C and stored for 7 days. Finally, the brains were sliced at a thickness of 100 μm with oscillating tissue slicers, stained and then mounted on gelatin-coated slides. After alcohol dehydration, the tissue sections were cleared in xylene and coverslipped. The hippocampal neurons were captured by an EVOS FL auto microscope (Life technology) under Z-stack mode (× 20 object) for dendritic analysis. The dendrites from hippocampal neurons in CA1 region were captured with a confocal microscope (× 100 oil objective). Dendrite branches were traced by the NeuronJ plugin in ImageJ software, and the dendritic length was calculated. Sholl analysis was applied to measure the dendritic intersections in concentric circles per 20 μm from the cell soma. Dendritic spine density was detected along CA1 secondary dendrites starting from their point of origin on the primary dendrite, and the counting was performed by an experimenter blinded to the group of each sample.

Statistical analysis

Statistical analyses were analyzed by the GraphPad Prism version 8.0 statistical package (Graphpad Software, Inc.). Data are presented as mean ± S.E.M. Differences between groups were assessed with one-way ANOVA followed by post hoc Tukey multiple comparisons. The dendritic intersections were analyzed by repeated-measures ANOVA followed by post hoc Tukey multiple comparisons. A significant difference was considered as p < 0.05.

Results

Inhibition of NMDAR attenuated the activation of microglia and astrocytes and proinflammatory cytokines after anesthesia and surgery

We performed immunostaining by using antibodies of Iba1 and GFAP on day 1 post-surgery, respectively. Compared with control + vehicle (con + veh) group, the intensity of Iba1 [F(3, 20) = 16.34, p < 0.0001; Fig. 2a, c] and GFAP [F(3, 20) = 20.06, p < 0.0001; Fig. 2b, d] was significantly increased in the hippocampus in surgery + vehicle (sur + veh) group. Notably, memantine treatment could attenuate anesthesia and surgery-induced activation of microglia and astrocytes.

Fig. 2
figure 2

Anesthesia and surgery-induced activation of microglia and astrocytes in the hippocampus was attenuated by MEM treatment on day 1 post-surgery. a Representative images of Iba-1 (a marker of microglia) in the hippocampus. b Representative images of GFAP (a marker of astrocytes) in the hippocampus. c Quantification of Iba-1 fluorescence. d Quantification of GFAP fluorescence. Data are presented as the mean ± SEM (n = 6). *p < 0.05 compared to the con + veh group (**p < 0.01, ***p < 0.001), #p < 0.05 compared to the sur + veh group (##p < 0.01, ###p < 0.001). DAPI staining is shown in blue. Scale bar = 50 μm

Full size image

Next, we detected the levels of proinflammatory cytokines on days 1 and 8 post-surgery. On day 1 post-surgery, the IL-1β [F(3, 20) = 14.55, p < 0.0001; Fig. 3a, b] and IL-6 [F(3, 20) = 19.50, p < 0.0001; Fig. 3c, d] levels were significantly increased in the sur + veh group, which was attenuated in the surgery + MEM (sur + MEM) group. On day 8 post-surgery, we also showed that the increased levels of IL-1β [F(3, 20) = 16.02, p < 0.0001; Fig. 4a, b] and IL-6 [F(3, 20) = 7.250, p = 0.0018; Fig. 4c, d] induced by anesthesia and surgery, which were reversed by memantine treatment. But there were no significant differences of tumor necrosis factor-α (TNF-α) among the groups [F(3, 20) = 0.6109, p = 0.6158; Fig. 3e, f]. The levels of GluN2A and GluN2B of the hippocampus were also measured using Western blot. GluN2A [F(3, 20) = 10.13, p = 0.0003; Fig. 3g, h] and GluN2B [F(3, 20) = 8.462, p = 0.0008; Fig. 3i, j] levels were significantly increased in the sur + veh group, which were reversed by memantine treatment.

Fig. 3
figure 3

Increased hippocampal levels of IL-1β, IL-6, and NMDAR subunits after anesthesia and surgery were attenuated by MEM treatment on day 1 post-surgery. a Representative Western blots of IL-1β in the hippocampus. GAPDH was included as a loading control. b Quantitative analysis of IL-1β levels. c Representative Western blots of IL-6 in the hippocampus. GAPDH was included as loading control. d Quantitative analysis of IL-6 levels. e Representative Western blots of TNF-α in the hippocampus. GAPDH was included as loading control. f Quantitative analysis of TNF-α levels. g Representative Western blots of GluN2A. GAPDH was included as loading control. h Quantitative analysis of GluN2A levels. i Representative Western blots of GluN2B. GAPDH was included as loading control. j Quantitative analysis of GluN2B levels. Data are presented as the mean ± SEM (n = 6). *p < 0.05 compared to the con + veh group (**p < 0.01, ***p < 0.001), #p < 0.05 compared to the sur + veh group (##p < 0.01, ###p < 0.001)

Full size image
Fig. 4
figure 4

Increased hippocampal levels of IL-1β and IL-6 after anesthesia and surgery were detected on day 8 post-surgery, which were attenuated by MEM treatment. a Representative Western blots of IL-1β in the hippocampus. β-tubulin was included as loading control. b Quantitative analysis of IL-1β levels. c Representative Western blots of IL-6 in the hippocampus. β-tubulin was included as loading control. d Quantitative analysis of IL-6 levels. Data are presented as the mean ± SEM (n = 6). *p < 0.05 compared to the con + veh group (**p < 0.01, ***p < 0.001), #p < 0.05 compared to the sur + veh group (##p < 0.01, ###p < 0.001)

Full size image

Inhibition of NMDAR limited the activation of calpain and TrkB-FL cleavage after anesthesia and surgery

To evaluate whether NMDAR inhibition by memantine could affect anesthesia and surgery-induced activation of calpain, we detected αII-spectrin levels and the formation of calpain-specific spectrin breakdown products (SBDPs). αII-spectrin is a major substrate for calpain and caspase-3 proteases. The activation of calpain could result in the cleavage of αII-spectrin and then produce breakdown products with distinct molecular weights. The expected molecular weight of αII-spectrin is 250 kDa, whereas the SBDP is 150 kDa. Our data showed that the levels of SBDPs were significantly increased, which was accompanied by decreased levels of αII-spectrin in the sur + veh group, suggesting the activation of calpain. However, this increase was ameliorated by memantine treatment [F(3, 20) = 234.5, p < 0.0001; Fig. 5a, b]. Next, we evaluated the effects of memantine on TrkB levels after anesthesia and surgery. We observed that anesthesia and surgery induced a marked decrease in TrkB-FL [F(3, 20) = 4.599, p = 0.0132; Fig. 5c, d] and a significant increase in TrkB-ICD levels [F(3, 20) = 4.854, p = 0.0107; Fig. 5e, f]. However, memantine treatment reversed these alterations (Fig. 5).

Fig. 5
figure 5

MEM treatment reduced the cleavage of TrkB by modulating the overactivation of calpain on day 1 post-surgery. a Representative Western blots of SBDP in the hippocampus. GAPDH was included as loading control. b Quantitative analysis of the ratio of the SBDP to αII-spectrin. c Representative Western blots of TrkB-FL. GAPDH was included as loading control. d Quantitative analysis of TrkB-FL levels. e Representative Western blots of TrkB-ICD. β-tubulin was included as loading control. f Quantitative analysis of TrkB-ICD levels. Data are presented as the mean ± SEM (n = 6). *p < 0.05 compared to the con + veh group (**p < 0.01, ***p < 0.001), #p < 0.05 compared to the sur + veh group (##p < 0.01, ###p < 0.001)

Full size image

Inhibition of NMDAR or calpain reversed BDNF/TrkB signaling disruption and decreased apoptosis after anesthesia and surgery

To determine whether TrkB is truncated by calpain activation, we administrated MDL-28170, an inhibitor of calpain. The levels of SBDPs were significantly increased and the levels of αII-spectrin were decreased after anesthesia and surgery, which were reversed by memantine or MDL-28170 treatment [F(5, 30) = 64.15, p < 0.0001; Fig. 6a, b]. BDNF levels were significantly decreased in the sur + veh group, whereas memantine or MDL-28170 treatment reversed the decreased BDNF levels [F(5, 30) = 4.064, p = 0.0062; Fig. 6c, d]. We also showed that anesthesia and surgery induced a marked decrease in TrkB-FL levels [F(5, 30) = 4.958, p = 0.0020; Fig. 6e, f] and a significant increase in TrkB-ICD levels [F(5, 30) = 4.325, p = 0.0044; Fig. 6g, h]. Again, memantine or MDL-28170 treatment reversed these alterations (Fig. 6).

Fig. 6
figure 6

Inhibition of NMDAR or calpain restored BDNF/TrkB signaling disruption on day 1 post-surgery. a Representative Western blots of SBDP in the hippocampus. β-tubulin was included as loading control. b Quantitative analysis of the ratio of the SBDP to αII-spectrin. c Representative Western blots of BDNF in the hippocampus. β-tubulin was included as loading control. d Quantitative analysis of BDNF levels. e Representative Western blots of TrkB-FL. β-tubulin was included as loading control. f Quantitative analysis of TrkB-FL levels. g Representative Western blots of TrkB-ICD. β-tubulin was included as loading control. h Quantitative analysis of TrkB-ICD levels. Data are presented as the mean ± SEM (n = 6). *p < 0.05 compared to the con + veh group (**p < 0.01, ***p < 0.001), #p < 0.05 compared to the sur + veh group (##p < 0.01, ###p < 0.001)

Full size image

The presence of calpain-cleaved fragments occurs early in neural cell pathology and may be indicative of necrotic and excitotoxic neuronal injury and death. As reported previously, cell apoptosis plays an important role in POCD. In the current study, we showed that the levels of bax [F(5, 30) = 8.311, p < 0.0001; Fig. 7a, b], bcl-2 [F(5, 30) = 3.739, p = 0.0095; Fig. 7c, d], and cleaved caspase-3 [F(5, 30) = 5.399, p = 0.0012; Fig. 7e, f] were significantly increased, and FL-caspase-3 [F(5, 30) = 4.754, p = 0.0026; Fig. 7e, f] levels were significantly decreased after anesthesia and surgery, while memantine or MDL-28170 treatment could reverse the above alterations (Fig. 7). We also observed that memantine treatment could reduce increased GluN2A [F(5, 30) = 19.98, p < 0.0001; Fig. 7g, h] and GluN2B [F(5, 30) = 17.00, p < 0.0001; Fig. 7i, j] levels after anesthesia and surgery. However, MDL-28170 treatment did not change NMDARs levels (Fig. 7).

Fig. 7
figure 7

Increased levels of markers associated with cell apoptosis were attenuated by MEM or MDL-28170 treatment on day 1 post-surgery. a Representative Western blots of bax in the hippocampus. β-tubulin was included as loading control. b Quantitative analysis of bax. c Representative Western blots of bcl-2. β-tubulin was included as loading control. d Quantitative analysis of bcl-2 levels. e Representative Western blots of FL-caspase-3 and cleaved caspase-3 in the hippocampus. β-tubulin was included as loading control. f Quantitative analysis of cleaved caspase-3 and FL-caspase-3 levels. g Representative western-blots of GluN2A. β-tubulin was included as loading control. h Quantitative analysis of GluN2A levels. i Representative Western blots of GluN2B. β-tubulin was included as loading control. j Quantitative analysis of GluN2B levels. Data are presented as the mean ± SEM (n = 6). *p < 0.05 compared to the con+ veh group (**p < 0.01, ***P < 0.001), #p < 0.05 compared to the sur + veh group (##p < 0.01, ###p < 0.001)

Full size image

Inhibition of NMDAR or calpain attenuated anesthesia and surgery-induced hippocampal dendritic spine loss

We used Sholl analysis to assess dendritic branching and spine density in the CA1 region in the hippocampus. There was no significant difference in the total number of dendritic intersections [F(5, 30) = 0.1977, p = 0.9609; Fig. 8c] and total dendritic length [F(5, 30) = 0.009950, p > 0.9999; Fig. 8d] among the six groups. However, the dendritic spine density was significantly reduced after anesthesia and surgery, while memantine or MDL-28170 treatment attenuated anesthesia and surgery-induced dendritic spine loss [F(5, 30) = 3.949, p = 0.0072; Fig. 8e, f].

Fig. 8
figure 8

Inhibition of NMDAR or calpain attenuated hippocampal dendritic density loss after anesthesia and surgery. a A hippocampal profile image of Golgi-Cox staining. b Representative camera tracings of hippocampal CA1 neurons of the six groups. c Quantitation of the dendritic intersections of the six groups. d Quantitation of the total dendritic length of the six groups. e Representative dendritic spine density of hippocampal CA1 neurons of the six groups. f Quantitation of the dendritic spine density of the six groups. Data are presented as the mean ± SEM (n = 6). *p < 0.05 compared to the con + veh group (**p < 0.01, ***p < 0.001), #p < 0.05 compared to the sur + veh group (##p < 0.01, ###p < 0.001)

Full size image

Inhibition of NMDAR or calpain attenuated cognitive impairments after anesthesia and surgery

The open field was used to evaluate the locomotor activity and exploratory behavior. During the 5-min test session, there was no significant difference in the total distance [F(5, 54) = 0.07516, p = 0.9957; Fig. 9a] and the time spent in the center of the arena [F(5, 54) = 0.05177, p = 0.9982; Fig. 9b] among the six groups at 5 days post-surgery. At 6 days post-surgery, mice were tested in the spontaneous alternation Y-maze paradigm that assesses spatial working memory. There was no significant difference in total arm entries among the six groups [F(5, 54) = 0.1552, p = 0.9776; Fig. 9c]. The mice in the sur + veh group displayed lesser spontaneous alteration than the mice in con + veh group, which was reversed by memantine or MDL-28170 treatment [F(5, 54) = 6.052, p = 0.0002; Fig. 9d]. At 8 days post-surgery, the contextual fear conditioning test was used to access the long-term memory. Mice in the sur + veh group displayed significantly decreased freezing time than those in the con + veh group in the contextual fear conditioning test, which was reversed by memantine or MDL-28170 treatment [F(5, 54) = 5.489, p = 0.0004; Fig. 9e].

Fig. 9
figure 9

Anesthesia and surgery-induced cognitive impairments were attenuated by MEM or MDL-28170 treatment. a, b There was no significant difference at ambulatory distance and time spent in the center in the open field test among the six groups at 5 days post-surgery. c There was no significant difference of the total arm entries in the Y maze test. d The mice in the sur + veh group displayed lesser spontaneous alteration than the mice in the con + veh group, which was reversed by MEM or MDL-28170 treatment. e The freezing time to context was significantly decreased after anesthesia and surgery, while MEM or MDL-28170 treatment evidently increased the freezing time. Data are presented as the mean ± SEM (n = 10). *p < 0.05 compared to the con+ veh group (**p < 0.01, ***p < 0.001), #p < 0.05 compared to the sur + veh group (##p < 0.01, ###p < 0.001)

Full size image

Discussion

In the present study, we showed that anesthesia and surgery-induced neuroinflammation overactivated NMDARs, and the abnormal activation of NMDARs triggered the overactivation of calpain, which subsequently led to the truncation of TrkB-FL, BDNF/TrkB signaling dysregulation, dendritic spine loss, and cell apoptosis, contributing to cognitive impairments in aging mice. Of note, NMDARs antagonist memantine or calpain inhibitor MDL-28170 attenuated these abnormalities, suggesting tackling abnormal activation of NMDARs or truncation of TrkB-FL may be a therapeutic strategy for POCD (Fig. 10).

Fig. 10
figure 10

General overview of the main highlights of this study. Anesthesia and surgery-induced neuroinflammation overactivated NMDARs and calpain, which subsequently led to the truncation of TrkB-FL, BDNF/TrkB signaling dysregulation, dendritic spine loss, and cell apoptosis, contributing to cognitive impairments in aging mice

Full size image

Patients suffering from cognitive impairments after anesthesia and surgery have been recognized for more than 60 years. Recently, a multi-specialty working group recommended “perioperative neurocognitive disorders” (PND) as an overarching term for cognitive impairments diagnosed in the preoperative or postoperative period [28,29,30,31,32,33]. PND includes cognitive decline diagnosed before operation (described as neurocognitive disorder), postoperative delirium (POD), delayed neurocognitive recovery, and POCD. Since we focused on cognitive performance during the postoperative period, we still used the term of POCD in the current study.

Although various mechanisms have been proposed to be involved in the development of POCD, neuroinflammation is believed to play an initial and central role. In the present study, we showed that IL-1β and IL-6 levels were significantly increased and lasted for 8 days post-surgery. Our results were consistent with the previous studies [15, 22, 34], suggesting that the hippocampus is susceptible to neuroinflammation induced by anesthesia and surgery. However, the mechanism by which neuroinflammation leading to cognitive impairments following anesthesia and surgery remains unclear.

There is accumulating evidence suggesting a strong correlation between neuroinflammation and NMDAR dysfunction, eventually resulting in deficits of synaptic plasticity and cognitive impairments. It has been showed that microglia is activated initially and become a major cellular source of a variety of proinflammatory cytokines in a rat model of chronic neuroinflammation, which has negative effect on long-term potentiation requiring NMDAR activation [35]. In addition, the anti-inflammatory agent indomethacin has been reported to improve cognitive impairments by inhibiting microglia activation and reversing NMDAR dysfunction in aged rats [21]. On the other hand, another study has showed that NMDA-induced retinal excitotoxicity could trigger microglia recruitment and IL-1β production [36]. In our study, we found that anesthesia and surgery induced neuroinflammation and NMDAR overactivation. Although we do not know which signaling works as an initial trigger, we speculate there is a possible cross-talk between neuroinflammation and NMDAR overactivation, leading to cognitive impairments in aging mice.

We previously demonstrated that NMDARs calcium/calmodulin-dependent kinase II pathway was involved in the pathogenesis of POCD [37]. Therefore, the present study tested the hypothesis that NMDARs may be implicated in the overactivation of calpain in POCD. NMDARs are ligand-gated ion channels, which have tetrameric structure composed of GluN1, GluN2A-D, and GluN3A-B subunits, forming di- or triheteromers with participation of GluN1. The most widely expressed NMDARs contain the obligatory subunit GluN1 plus either GluN2A or GluN2B or a mixture of the two. In particular, NR2B is involved in NMDA-mediated excitotoxicity [38], while NR2A is associated with human immunodeficiency virus-mediated neurotoxicity [39]. Here, we showed the levels of GluN2A and GluN2B were significantly increased after anesthesia and surgery. The treatment of memantine, a low-affinity uncompetitive NMDAR antagonist without affecting normal physiological activity, attenuated anesthesia and surgery-induced overactivation of NMDARs and calpain and improved cognitive impairments in aging mice. It has been previously demonstrated that memantine is neuroprotective in various brain diseases, including AD [40], Parkinson’s disease [41], traumatic brain injury [42], and pain-induced cognitive impairments [43], which involves its anti-inflammation, anti-oxidation, anti-apoptosis, and anti-glutamate excitotoxicity properties. In our study, we showed that NMDAR/Ca2+/calpain is mechanistically involved in neuroprotective effects of memantine in anesthesia and surgery-induced cognitive impairments in aging mice. In a rat model of postoperative pain-induced cognitive impairments, memantine treatment could improve memory deficits without any effect on NMDAR expression [43]. Interestingly, we showed that memantine downregulated the levels of GluN2A and GluN2B. Indeed, one previous study suggests that memantine inhibited ethanol-induced upregulation of NMDA receptor subunits GluN2A and GluN2B in rat hippocampal neurons [44]. Thus, this downregulation of GluN2A and GluN2B levels by memantine seems to be responsible for its neuroprotective effects in aging mice after anesthesia and surgery.

BDNF plays an important role in neuronal plasticity, learning, and memory through the activation of TrkB-FL receptors [4, 5]. It has been reported that reduced BDNF signaling through TrkB-FL leads to impaired memory [45, 46]. IL-1β has been shown to negatively regulate BDNF-dependent learning and memory in neurodegenerative diseases [47]. In our previous study, we demonstrated that anesthesia and surgery could induce microglial activation, I L-1β release, and BDNF downregulation in the hippocampus and thus resulted in hippocampus-dependent cognitive impairments in aged mice [15]. In support, we showed that microglia and astrocyte-induced neuroinflammation plays a crucial role in the development of POCD. Moreover, alteration in BDNF signaling can result in synaptic dysfunction that is associated with memory deficits observed in AD [48], Parkinson’s disease (PD) [41], stroke [49], and sepsis-associated encephalopathy [50]. In the present study, we showed that anesthesia and surgery induced decreased levels of BDNF, which could be reversed by memantine and MDL-28170. The results are consistent with a previous study in PD animal model [41]. Therefore, we speculate that neuroinflammation and overactivated calcium signaling pathway may contribute to the downregulation of BDNF levels after anesthesia and surgery in aging mice. However, it remains unclear whether the alteration of TrkB is involved in the development of POCD.

TrkB is expressed as a full-length, catalytically active isoform (TrkB-FL), as well as several alternatively spliced truncated isoforms lacking the intracellular kinase domain, including TrkB.T1, TrkB.T2, and TrkB.T-Shc [51, 52]. Both TrkB-FL and TrkB-TC are widely expressed throughout the adult mammalian CNS [53]. Abnormal levels of TrkB-TC have been reported in several neurodegenerative disorders, such as AD [11], Down syndrome [12], and amyotrophic lateral sclerosis [54]. It has been reported that overexpression of TrkB-FL improves spatial memory in mice [55], whereas overexpression of TrkB.T1 slightly impairs it [46]. In a mouse model of Down syndrome, the accelerated death of hippocampal neurons is not rescued by exogenous BDNF delivery [12] but instead by restoring the physiological levels of TrkB.T1 [56]. In a mouse model of spinal cord injury, the increased levels of TrkB.T1 contribute to locomotor dysfunction and neuropathic pain [57]. In the present study, we showed that expression of TrkB-FL was significantly decreased after anesthesia and surgery, whereas TrkB-ICD was significantly increased. Increasing evidence has showed that excitotoxicity is associated with the downregulation of TrkB-FL and upregulation of TrkB-TC expression [14]. The abnormal activation of calpain has been shown to associate with excitotoxicity and mediates neuronal injury by cleavage on TrkB-FL receptor in stroke and ischemic neurodegeneration [58]. It has also been demonstrated that Aβ induced a calpain-mediated cleavage on TrkB-FL receptors, producing a new truncated TrkB receptor (TrkB-T′) and a 32-kDa intracellular fragment (TrkB-ICD), which was also detected in postmortem human brain samples [11]. Besides, the overactivation of calpain has been associated with several neuropsychiatric disorders, including Huntington’s disease [59], Parkinson’s disease [60], and brain trauma [61]. In our study, anesthesia and surgery induced overactivation of calpain and subsequently resulted in increased TrkB-ICD and decreased TrkB-FL levels, which were rescued by calpain inhibitor MDL-28170. This suggests that the strategy targeting at calpain is a promising therapeutic strategy for cognitive impairment after anesthesia and surgery.

There are some limitations in this study. Firstly, we mainly observed relatively short-term cognitive performance by Y maze and fear conditioning tests after anesthesia and surgery. Using Morris water maze to measure spatial cognition are needed in our future studies. Secondly, memantine is a partial antagonist of NMDAR receptor that block the pathological activation of NMDARs, while not interfering with normal synaptic transmission [62]. Clinically, memantine is a commercially available and FDA-approved drug used for the treatment of AD patients. That is the reason why we did not use the selective GluN2A and GluN2B subunit antagonists in this study. In addition, we only detected a 32-kDa intracellular fragment (TrkB-ICD), but not new truncated TrkB receptor, which deserves further study in the future.

Conclusions

In summary, our study demonstrated that neuroinflammation overactivated NMDARs, at least in part, plays a key role in overactivation of calpain, cleavage of TrkB-FL receptor, BDNF/TrkB signaling dysfunction, dendritic spine loss, cell apoptosis, and consequent cognitive impairments. Hence, identifying viable therapeutic strategies to tackle abnormal activation of NMDARs or calpain may provide effective interventions for POCD.

Availability of data and materials

The data supporting the findings of this study are presented within the manuscript.

Abbreviations

Aβ:

Amyloid-β

BDNF:

Brain-derived neurotrophic factor

BSA:

Bovine serum albumin

DAPI:

4′,6-diamidino-2-pheny-lindole

i.p. :

Intraperitoneally

ICD:

An intracellular domain

IL-1β:

Interleukin-1β

MEM:

Memantine

NMDAR:

N-methyl-d-aspartate receptor

NSAIDs:

Nonsteroidal anti-inflammatory drugs

PBS:

Phosphate-buffered saline

PFA:

Paraformaldehyde

PND:

Perioperative neurocognitive disorders

POCD:

Postoperative cognitive decline

POD:

Postoperative delirium

SBDPs:

Calpain-specific spectrin breakdown products

TNF-α:

Tumor necrosis factor-α

TrkB-FL:

TrkB-full length

TrkB-T′:

New truncated TrkB

TrkB-TC:

Truncated isoforms of TrkB

References

  1. Terrando N, Brzezinski M, Degos V, Eriksson LI, Kramer JH, Leung JM, Miller BL, Seeley WW, Vacas S, Weiner MW, et al. Perioperative cognitive decline in the aging population. Mayo Clin Proc. 2011;86:885–93.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hovens IB, Schoemaker RG, van der Zee EA, Heineman E, Izaks GJ, van Leeuwen BL. Thinking through postoperative cognitive dysfunction: how to bridge the gap between clinical and pre-clinical perspectives. Brain Behav Immun. 2012;26:1169–79.

    Article  PubMed  Google Scholar 

  3. Deo H, West G, Butcher C, Lewis P. The prevalence of cognitive dysfunction after conventional and computer-assisted total knee replacement. Knee. 2011;18:117–20.

    Article  PubMed  CAS  Google Scholar 

  4. Lewin GR, Barde YA. Physiology of the neurotrophins. Annu Rev Neurosci. 1996;19:289–317.

    Article  PubMed  CAS  Google Scholar 

  5. Lu B, Nagappan G, Guan X, Nathan PJ, Wren P. BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci. 2013;14:401–16.

    Article  PubMed  CAS  Google Scholar 

  6. Schober ME, Block B, Requena DF, Hale MA, Lane RH. Developmental traumatic brain injury decreased brain derived neurotrophic factor expression late after injury. Metab Brain Dis. 2012;27:167–73.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Rostami E, Krueger F, Plantman S, Davidsson J, Agoston D, Grafman J, Risling M. Alteration in BDNF and its receptors, full-length and truncated TrkB and p75(NTR) following penetrating traumatic brain injury. Brain Res. 2014;1542:195–205.

    Article  PubMed  CAS  Google Scholar 

  8. Vidaurre OG, Gascon S, Deogracias R, Sobrado M, Cuadrado E, Montaner J, Rodriguez-Pena A, Diaz-Guerra M. Imbalance of neurotrophin receptor isoforms TrkB-FL/TrkB-T1 induces neuronal death in excitotoxicity. Cell Death Dis. 2012;3:e256.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Tejeda GS, Ayuso-Dolado S, Arbeteta R, Esteban-Ortega GM, Vidaurre OG, Diaz-Guerra M. Brain ischaemia induces shedding of a BDNF-scavenger ectodomain from TrkB receptors by excitotoxicity activation of metalloproteinases and gamma-secretases. J Pathol. 2016;238:627–40.

    Article  PubMed  CAS  Google Scholar 

  10. Plotkin JL, Day M, Peterson JD, Xie Z, Kress GJ, Rafalovich I, Kondapalli J, Gertler TS, Flajolet M, Greengard P, et al. Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington’s disease. Neuron. 2014;83:178–88.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Jeronimo-Santos A, Vaz SH, Parreira S, Rapaz-Lerias S, Caetano AP, Buee-Scherrer V, Castren E, Valente CA, Blum D, Sebastiao AM, Diogenes MJ. Dysregulation of TrkB receptors and BDNF function by amyloid-beta peptide is mediated by calpain. Cereb Cortex. 2015;25:3107–21.

    Article  PubMed  Google Scholar 

  12. Dorsey SG, Bambrick LL, Balice-Gordon RJ, Krueger BK. Failure of brain-derived neurotrophic factor-dependent neuron survival in mouse trisomy 16. J Neurosci. 2002;22:2571–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Carim-Todd L, Bath KG, Fulgenzi G, Yanpallewar S, Jing D, Barrick CA, Becker J, Buckley H, Dorsey SG, Lee FS, Tessarollo L. Endogenous truncated TrkB.T1 receptor regulates neuronal complexity and TrkB kinase receptor function in vivo. J Neurosci. 2009;29:678–85.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Gomes JR, Costa JT, Melo CV, Felizzi F, Monteiro P, Pinto MJ, Inacio AR, Wieloch T, Almeida RD, Graos M, Duarte CB. Excitotoxicity downregulates TrkB.FL signaling and upregulates the neuroprotective truncated TrkB receptors in cultured hippocampal and striatal neurons. J Neurosci. 2012;32:4610–22.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Qiu LL, Ji MH, Zhang H, Yang JJ, Sun XR, Tang H, Wang J, Liu WX, Yang JJ. NADPH oxidase 2-derived reactive oxygen species in the hippocampus might contribute to microglial activation in postoperative cognitive dysfunction in aged mice. Brain Behav Immun. 2016;51:109–18.

    Article  PubMed  CAS  Google Scholar 

  16. Gladding CM, Sepers MD, Xu J, Zhang LY, Milnerwood AJ, Lombroso PJ, Raymond LA. Calpain and STriatal-enriched protein tyrosine phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington’s disease mouse model. Hum Mol Genet. 2012;21:3739–52.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Danelon V, Montroull LE, Unsain N, Barker PA, Masco DH. Calpain-dependent truncated form of TrkB-FL increases in neurodegenerative processes. Mol Cell Neurosci. 2016;75:81–92.

    Article  PubMed  CAS  Google Scholar 

  18. Andres AL, Regev L, Phi L, Seese RR, Chen Y, Gall CM, Baram TZ. NMDA receptor activation and calpain contribute to disruption of dendritic spines by the stress neuropeptide CRH. J Neurosci. 2013;33:16945–60.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Sugiyama K, Aida T, Nomura M, Takayanagi R, Zeilhofer HU, Tanaka K. Calpain-dependent degradation of nucleoporins contributes to motor neuron death in a mouse model of chronic excitotoxicity. J Neurosci. 2017;37:8830–44.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Tanqueiro SR, Ramalho RM, Rodrigues TM, Lopes LV, Sebastiao AM, Diogenes MJ. Inhibition of NMDA receptors prevents the loss of BDNF function induced by amyloid beta. Front Pharmacol. 2018;9:237.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Kumar A, Rani A, Scheinert RB, Ormerod BK, Foster TC. Nonsteroidal anti-inflammatory drug, indomethacin improves spatial memory and NMDA receptor function in aged animals. Neurobiol Aging. 2018;70:184–93.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Cibelli M, Fidalgo AR, Terrando N, Ma D, Monaco C, Feldmann M, Takata M, Lever IJ, Nanchahal J, Fanselow MS, Maze M. Role of interleukin-1beta in postoperative cognitive dysfunction. Ann Neurol. 2010;68:360–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Qiu LL, Luo D, Zhang H, Shi YS, Li YJ, Wu D, Chen J, Ji MH, Yang JJ. Nox-2-mediated phenotype loss of hippocampal parvalbumin interneurons might contribute to postoperative cognitive decline in aging mice. Front Aging Neurosci. 2016;8:234.

    PubMed  PubMed Central  Google Scholar 

  24. Zhang G, Dong Y, Zhang B, Ichinose F, Wu X, Culley DJ, Crosby G, Tanzi RE, Xie Z. Isoflurane-induced caspase-3 activation is dependent on cytosolic calcium and can be attenuated by memantine. J Neurosci. 2008;28:4551–60.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Thompson SN, Carrico KM, Mustafa AG, Bains M, Hall ED. A pharmacological analysis of the neuroprotective efficacy of the brain- and cell-permeable calpain inhibitor MDL-28170 in the mouse controlled cortical impact traumatic brain injury model. J Neurotrauma. 2010;27:2233–43.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Hughes RN. The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. Neurosci Biobehav Rev. 2004;28:497–505.

    Article  PubMed  CAS  Google Scholar 

  27. Gibb R, Kolb B. A method for vibratome sectioning of Golgi-Cox stained whole rat brain. J Neurosci Methods. 1998;79:1–4.

    Article  PubMed  CAS  Google Scholar 

  28. Evered L, Silbert B, Knopman DS, Scott DA, DeKosky ST, Rasmussen LS, Oh ES, Crosby G, Berger M, Eckenhoff RG, Nomenclature Consensus Working Group f. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018. Can J Anaesth. 2018;65:1248–57.

    Article  PubMed  CAS  Google Scholar 

  29. Evered L, Silbert B, Knopman DS, Scott DA, DeKosky ST, Rasmussen LS, Oh ES, Crosby G, Berger M, Eckenhoff RG, Nomenclature Consensus Working G. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018. Acta Anaesthesiol Scand. 2018;62:1473–80.

    Article  PubMed  Google Scholar 

  30. Evered L, Silbert B, Knopman DS, Scott DA, DeKosky ST, Rasmussen LS, Oh ES, Crosby G, Berger M, Eckenhoff RG, Nomenclature Consensus Working G. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018. Anesth Analg. 2018;127:1189–95.

    Article  PubMed  CAS  Google Scholar 

  31. Evered L, Silbert B, Knopman DS, Scott DA, DeKosky ST, Rasmussen LS, Oh ES, Crosby G, Berger M, Eckenhoff RG, Nomenclature Consensus Working G. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018. Anesthesiology. 2018;129:872–9.

    Article  PubMed  CAS  Google Scholar 

  32. Evered L, Silbert B, Knopman DS, Scott DA, DeKosky ST, Rasmussen LS, Oh ES, Crosby G, Berger M, Eckenhoff RG, Nomenclature Consensus Working G. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018. Br J Anaesth. 2018;121:1005–12.

    Article  PubMed  CAS  Google Scholar 

  33. Evered L, Silbert B, Knopman DS, Scott DA, DeKosky ST, Rasmussen LS, Oh ES, Crosby G, Berger M, Eckenhoff RG, Nomenclature Consensus Working G. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018. J Alzheimers Dis. 2018;66:1–10.

    Article  PubMed  CAS  Google Scholar 

  34. Femenia T, Gimenez-Cassina A, Codeluppi S, Fernandez-Zafra T, Katsu-Jimenez Y, Terrando N, Eriksson LI, Gomez-Galan M. Disrupted neuroglial metabolic coupling after peripheral surgery. J Neurosci. 2018;38:452–64.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Ma J, Choi BR, Chung C, Min SS, Jeon WK, Han JS. Chronic brain inflammation causes a reduction in GluN2A and GluN2B subunits of NMDA receptors and an increase in the phosphorylation of mitogen-activated protein kinases in the hippocampus. Mol Brain. 2014;7:33.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Tsoka P, Barbisan PR, Kataoka K, Chen XN, Tian B, Bouzika P, Miller JW, Paschalis EI, Vavvas DG. NLRP3 inflammasome in NMDA-induced retinal excitotoxicity. Exp Eye Res. 2019;181:136–44.

    Article  PubMed  CAS  Google Scholar 

  37. Jia M, Liu WX, Sun HL, Chang YQ, Yang JJ, Ji MH, Yang JJ, Feng CZ. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, attenuates postoperative cognitive dysfunction in aging mice. Front Mol Neurosci. 2015;8:52.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. Ferreira IL, Bajouco LM, Mota SI, Auberson YP, Oliveira CR, Rego AC. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures. Cell Calcium. 2012;51:95–106.

    Article  PubMed  CAS  Google Scholar 

  39. O'Donnell LA, Agrawal A, Jordan-Sciutto KL, Dichter MA, Lynch DR, Kolson DL. Human immunodeficiency virus (HIV)-induced neurotoxicity: roles for the NMDA receptor subtypes. J Neurosci. 2006;26:981–90.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Kodis EJ, Choi S, Swanson E, Ferreira G, Bloom GS. N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-beta oligomers to ectopic neuronal cell cycle reentry in Alzheimer’s disease. Alzheimers Dement. 2018;14:1302–12.

    Article  PubMed  Google Scholar 

  41. Zhu G, Li J, He L, Wang X, Hong X. MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway. Br J Pharmacol. 2015;172:2354–68.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  42. Ma G, Liu C, Hashim J, Conley G, Morriss N, Meehan WP, Qiu J, Mannix R. Memantine mitigates oligodendrocyte damage after repetitive mild traumatic brain injury. Neuroscience. 2019;421:152–61.

    Article  PubMed  CAS  Google Scholar 

  43. Chi H, Kawano T, Tamura T, Iwata H, Takahashi Y, Eguchi S, Yamazaki F, Kumagai N, Yokoyama M. Postoperative pain impairs subsequent performance on a spatial memory task via effects on N-methyl-D-aspartate receptor in aged rats. Life Sci. 2013;93:986–93.

    Article  PubMed  CAS  Google Scholar 

  44. Maler JM, Esselmann H, Wiltfang J, Kunz N, Lewczuk P, Reulbach U, Bleich S, Ruther E, Kornhuber J. Memantine inhibits ethanol-induced NMDA receptor up-regulation in rat hippocampal neurons. Brain Res. 2005;1052:156–62.

    Article  PubMed  CAS  Google Scholar 

  45. Minichiello L. TrkB signalling pathways in LTP and learning. Nat Rev Neurosci. 2009;10:850–60.

    Article  PubMed  CAS  Google Scholar 

  46. Saarelainen T, Pussinen R, Koponen E, Alhonen L, Wong G, Sirvio J, Castren E. Transgenic mice overexpressing truncated trkB neurotrophin receptors in neurons have impaired long-term spatial memory but normal hippocampal LTP. Synapse. 2000;38:102–4.

    Article  PubMed  CAS  Google Scholar 

  47. Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S. New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res Rev. 2008;59:201–20.

    Article  PubMed  CAS  Google Scholar 

  48. Wang ZH, Xiang J, Liu X, Yu SP, Manfredsson FP, Sandoval IM, Wu S, Wang JZ, Ye K. Deficiency in BDNF/TrkB neurotrophic activity stimulates delta-secretase by upregulating C/EBPbeta in Alzheimer’s disease. Cell Rep. 2019;28:655–669 e655.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Tejeda GS, Esteban-Ortega GM, San Antonio E, Vidaurre OG, Diaz-Guerra M. Prevention of excitotoxicity-induced processing of BDNF receptor TrkB-FL leads to stroke neuroprotection. EMBO Mol Med. 2019;11:e9950.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  50. Wu J, Dong L, Zhang M, Jia M, Zhang G, Qiu L, Ji M, Yang J. Class I histone deacetylase inhibitor valproic acid reverses cognitive deficits in a mouse model of septic encephalopathy. Neurochem Res. 2013;38:2440–9.

    Article  PubMed  CAS  Google Scholar 

  51. Middlemas DS, Lindberg RA, Hunter T. trkB, a neural receptor protein-tyrosine kinase: evidence for a full-length and two truncated receptors. Mol Cell Biol. 1991;11:143–53.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  52. Ninkina N, Adu J, Fischer A, Pinon LG, Buchman VL, Davies AM. Expression and function of TrkB variants in developing sensory neurons. EMBO J. 1996;15:6385–93.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  53. Yan Q, Radeke MJ, Matheson CR, Talvenheimo J, Welcher AA, Feinstein SC. Immunocytochemical localization of TrkB in the central nervous system of the adult rat. J Comp Neurol. 1997;378:135–57.

    Article  PubMed  CAS  Google Scholar 

  54. Quarta E, Fulgenzi G, Bravi R, Cohen EJ, Yanpallewar S, Tessarollo L, Minciacchi D. Deletion of the endogenous TrkB.T1 receptor isoform restores the number of hippocampal CA1 parvalbumin-positive neurons and rescues long-term potentiation in pre-symptomatic mSOD1(G93A) ALS mice. Mol Cell Neurosci. 2018;89:33–41.

    Article  PubMed  CAS  Google Scholar 

  55. Koponen E, Voikar V, Riekki R, Saarelainen T, Rauramaa T, Rauvala H, Taira T, Castren E. Transgenic mice overexpressing the full-length neurotrophin receptor trkB exhibit increased activation of the trkB-PLCgamma pathway, reduced anxiety, and facilitated learning. Mol Cell Neurosci. 2004;26:166–81.

    Article  PubMed  CAS  Google Scholar 

  56. Dorsey SG, Renn CL, Carim-Todd L, Barrick CA, Bambrick L, Krueger BK, Ward CW, Tessarollo L. In vivo restoration of physiological levels of truncated TrkB.T1 receptor rescues neuronal cell death in a trisomic mouse model. Neuron. 2006;51:21–8.

    Article  PubMed  CAS  Google Scholar 

  57. Matyas JJ, O'Driscoll CM, Yu L, Coll-Miro M, Daugherty S, Renn CL, Faden AI, Dorsey SG, Wu J. Truncated TrkB.T1-mediated astrocyte dysfunction contributes to impaired motor function and neuropathic pain after spinal cord injury. J Neurosci. 2017;37:3956–71.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  58. Bevers MB, Neumar RW. Mechanistic role of calpains in postischemic neurodegeneration. J Cereb Blood Flow Metab. 2008;28:655–73.

    Article  PubMed  CAS  Google Scholar 

  59. Weber JJ, Kloock SJ, Nagel M, Ortiz-Rios MM, Hofmann J, Riess O, Nguyen HP. Calpastatin ablation aggravates the molecular phenotype in cell and animal models of Huntington disease. Neuropharmacology. 2018;133:94–106.

    Article  PubMed  CAS  Google Scholar 

  60. Samantaray S, Knaryan VH, Shields DC, Banik NL. Critical role of calpain in spinal cord degeneration in Parkinson’s disease. J Neurochem. 2013;127:880–90.

    Article  PubMed  CAS  Google Scholar 

  61. Wang Y, Liu Y, Lopez D, Lee M, Dayal S, Hurtado A, Bi X, Baudry M. Protection against TBI-induced neuronal death with post-treatment with a selective calpain-2 inhibitor in mice. J Neurotrauma. 2018;35:105–17.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Chen HS, Lipton SA. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J Physiol. 1997;499(Pt 1):27–46.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Acknowledgements

We thank Jiangsu Key Laboratory of Molecular Imaging and Functional Imaging for technical support and Jiangsu Key Laboratory of Developmental Genes and Human Diseases for providing the confocal microscope.

Funding

This work was supported by the grants from the National Natural Science Foundation of China (Nos., 81600950, 81971892) and by the Fundamental Research Funds for the Central Universities (Number 2242017 K41013).

Author information

Author notes

  1. Li-Li Qiu and Wei Pan share equal first authorship.

Authors and Affiliations

  1. Department of Anesthesiology, Zhongda Hospital, School of Medicine, Southeast University, No. 87 Dingjiaqiao Road, Nanjing, 210009, China

    Li-Li Qiu, Dan Luo, Guang-Fen Zhang & Mu-Huo Ji

  2. Department of Anesthesiology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

    Wei Pan

  3. Department of Anesthesiology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China

    Zhi-Qiang Zhou & Xiao-Yun Sun

  4. Department of Anesthesiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    Jian-Jun Yang

Authors
  1. Li-Li Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dan Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Guang-Fen Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhi-Qiang Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiao-Yun Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jian-Jun Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mu-Huo Ji
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

LLQ and WP carried out the Western blotting analysis and drafted the manuscript. DL and XYS performed behavioral tests. GFZ performed the immunofluorescence. ZQZ performed statistical analysis. JJY and MHJ designed the study and helped to draft the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Jian-Jun Yang or Mu-Huo Ji.

Ethics declarations

Ethics approval and consent to participate

The Ethics Committee of Zhongda Hospital, Medical School, Southeast University, approved all animal experiments described in this study.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qiu, LL., Pan, W., Luo, D. et al. Dysregulation of BDNF/TrkB signaling mediated by NMDAR/Ca2+/calpain might contribute to postoperative cognitive dysfunction in aging mice. J Neuroinflammation 17, 23 (2020). https://doi.org/10.1186/s12974-019-1695-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12974-019-1695-x

Keywords

Journal of Neuroinflammation

ISSN: 1742-2094